The Expanded Program on Immunization (EPI) in China, initiated by WHO in 1974, has significantly reduced disease burden by vaccinating against eight pathogens, averting an estimated 703 million cases and 2.48 million deaths over 50 years. The program has also generated substantial economic benefits, with a cost-benefit ratio of 19.48 from a societal perspective.
Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling study
Reference
Chaofan Wang, Xiaozhen Lai, Kaja Abbas, Koen B Pouwels, Haijun Zhang, Prof Mark Jit, Prof Hai Fang, Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling study, Lancet Public Health 2025, 23 Apr 2025
Published On
01 May 2025
Country
Tags
Source
Chaofan Wang, Xiaozhen Lai, Kaja Abbas, Koen B Pouwels, Haijun Zhang, Prof Mark Jit, Prof Hai Fang, Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling study, Lancet Public Health 2025, 23 Apr 2025